Cinnamon Cinnamomum verum (Ceylon); Cinnamomum cassia (cassia; synonym C. aromaticum)
Also called: Ceylon cinnamon, cassia cinnamon, cinnamon bark, Cinnamomum cassia, Cinnamomum zeylanicum
Cinnamon comes from trees of the genus Cinnamomum, mainly Ceylon cinnamon (Cinnamomum verum) and cassia cinnamon (Cinnamomum aromaticum). The bark, leaves, flowers, fruits and roots have traditional uses; supplements may not state the species or part.
- Category
- Botanical
- Part used
- Bark (products may not specify the part)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2012 Cochrane review identified 10 randomized controlled trials (577 participants with type 1 or type 2 diabetes) of oral cinnamon monopreparations versus placebo, active medication or no treatment. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CLungs and airways1 topic
CBlood sugar and weight1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood sugar in type 1 or type 2 diabetes | C | Cochrane 2012: 10 RCTs, 577 participants, mostly cassia at a mean 2 g daily for 4 to 16 weeks; no significant HbA1c difference versus control, fasting glucose inconclusive, evidence insufficient. [2] |
| Hay fever symptoms (nasal spray) | C | Preliminary research, including a randomized placebo-controlled trial, suggests a nasal spray with Ceylon cinnamon extract may improve hay fever symptoms; more reliable evidence is needed. [1] |
Main constituents: Coumarin (in cassia cinnamon; trace amounts may occur in Ceylon cinnamon) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Diabetes trials in the 2012 Cochrane review: mean 2 g daily, mostly Cinnamomum cassia tablets or capsules, for 4 to 16 weeks. [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score DABCDEA: well known causeE: unlikely cause
NIH LiverTox (last update July 1, 2026): likelihood score D, "possible rare cause of clinically apparent liver injury".
Details and sources - Pregnancy and breastfeedingNCCIH: some studies suggest Ceylon and cassia cinnamon are safe during pregnancy in amounts commonly found in foods, but Ceylon cinnamon in larger …
2 statements in the profile.
Details and sources - Interactions with medicines1 listed
An anticancer medicine; nicotine
Details and sources - Cancer evaluations (IARC, NTP)3 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notifications5 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Community herbal monograph on Cinnamomum verum J.S. Presl, cortex (EMA HMPC, adopted 10 May 2011), traditional use, adults and elderly: herbal tea …
Details and sources
- Cassia cinnamon contains coumarin, which has been linked to liver effects; food amounts usually do not reach problematic levels, but some cassia products contain high coumarin levels. Long-term use may be a concern for people with liver disease. [1]
- Larger amounts or long-term use may cause digestive problems or allergic reactions; topical cinnamon oil or powder may cause skin irritation or contact dermatitis. [1]
- Pregnancy: food amounts appear safe; larger amounts of Ceylon cinnamon during pregnancy are considered unsafe. Little is known about larger amounts during breastfeeding. [1]
- Adverse events in the Cochrane diabetes trials were infrequent and generally mild. [2]
Interactions
| With | What happens |
|---|---|
| An anticancer medicine; nicotine | NCCIH notes that some cinnamon components may theoretically interact with an anticancer medicine or nicotine. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Studies often do not identify the species or plant part tested, which makes results hard to interpret; coumarin content differs by species and product. [1]
Regulatory status
- US: sold as a dietary supplement ingredient; dietary supplements are not approved by the FDA before sale, and manufacturers are responsible for safety and labeling. [1]
- EU: the EMA lists a community herbal monograph for cinnamon bark (Cinnamomi cortex, Cinnamomum verum) in the gastrointestinal disorders area, first published 05/08/2011. [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Cinnamaldehyde (main constituent) Phenylpropanoid aldehyde [P4]
- Eugenol, cinnamyl acetate, cinnamyl alcohol, cinnamic acid, proanthocyanidins and coumarin (lesser constituents) Phenylpropanoids, flavonoid polymers (proanthocyanidins), coumarin [P4]
- Coumarin: only traces in C. verum bark; substantial amounts in cassia barks (C. cassia, C. loureiroi, C. burmannii) Coumarin [P7]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 5 entries naming cinnamon or Cinnamomum (NDI 192, 247, 810, 877 and 1304; earliest NDI 192 submitted 2002-12-09; most recent NDI 1304 submitted 2023-08-21). Four are multi-ingredient combinations (NDI 877 lists "Ralmulous cinnamomi" [sic]); entries for the mushroom Antrodia cinnamomea are not counted. Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of cinnamon (Cinnamomum bark) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
- Constituents evaluated as single compounds (not cinnamon): IARC classifies coumarin in Group 3 (Supplement 7 and Volume 77, 2000). [P3]
- NTP TR-422 (1993), coumarin by gavage: some evidence of carcinogenic activity in male F344/N rats (renal tubule adenomas), equivocal evidence in female rats, some evidence in male B6C3F1 mice and clear evidence in female B6C3F1 mice (alveolar/bronchiolar and hepatocellular tumors). This is the pure compound, not cinnamon. [P8]
- NTP TR-514 (2004), microencapsulated trans-cinnamaldehyde in feed: no evidence of carcinogenic activity in male or female F344/N rats or B6C3F1 mice at 1,000, 2,100 or 4,100 ppm. [P9]
Liver (NIH LiverTox)
- NIH LiverTox (last update July 1, 2026): likelihood score D, "possible rare cause of clinically apparent liver injury". LiverTox states the mechanism by which cinnamon might cause liver injury is not known, possibly related to the presence of coumarin in cinnamon preparations. [P4]
- NCCIH: interactions between coumarin, a chemical found in cassia cinnamon, and the liver have been reported; some cassia products contain high levels of coumarin, and prolonged use of cassia cinnamon could be an issue for sensitive people, such as those with liver disease. [P5]
Interactions with medicines
- An anticancer medicine; nicotine: NCCIH: some components of cinnamon may interact with an anticancer medicine or nicotine (a theoretical concern). [P5]
- Medicinal products (EU monograph): EU herbal monograph on Cinnamomum verum bark (2011): interactions with other medicinal products: none reported. [P6]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- Peru balsam (hypersensitivity): EU herbal monograph (2011): contraindicated in hypersensitivity to the active substance or to Peru balsam. [P6]
Adulteration and substitution
- Wang et al. (J Agric Food Chem 2013, NCNPR): cassia species (C. cassia, C. loureiroi, C. burmannii) are also sold in the US as cinnamon; coumarin was detected in all locally bought cinnamon, cinnamon-flavored foods and cinnamon food supplements tested, and chemical profiles indicated these were probably Indonesian cassia, C. burmannii. Analysis used a validated UPLC-UV/MS method for coumarin and other marker compounds. [P7]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
- Species identity (C. verum vs cassia) and coumarin assay, e.g. validated UPLC-UV/MS — Cassia species are sold as cinnamon in the US and contain substantial coumarin, whereas C. verum bark contains only traces (Wang et al. 2013). [P7]
- Compliance with the Ph. Eur. monograph for cinnamon (ref. 04/2011:0387) — The EU herbal monograph states the material complies with Ph. Eur. monograph 0387. [P6]
Supply and conservation
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Community herbal monograph on Cinnamomum verum J.S. Presl, cortex (EMA HMPC, adopted 10 May 2011), traditional use, adults and elderly: herbal tea 0.5–1 g comminuted herbal substance as an infusion, up to 4 times daily; liquid extract (DER 1:1, ethanol 70% V/V) single dose 0.5–1 ml, 3 times daily; tincture (1:5, ethanol 70% V/V) daily dose 2–4 ml. Use under 18 years is not recommended (EU). [P6]
Pregnancy and breastfeeding
- NCCIH: some studies suggest Ceylon and cassia cinnamon are safe during pregnancy in amounts commonly found in foods, but Ceylon cinnamon in larger amounts during pregnancy is considered unsafe; little is known about larger amounts while breastfeeding. [P5]
- EU herbal monograph (2011): safety during pregnancy and lactation has not been established; in the absence of sufficient data, use during pregnancy and lactation is not recommended. [P6]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- NIH LiverTox. Cinnamon (last update July 1, 2026), 2026-07-01. ncbi.nlm.nih.gov
- NCCIH. Cinnamon (last updated November 2024), 2024-11. nccih.nih.gov
- EMA HMPC. Community herbal monograph on Cinnamomum verum J.S. Presl, cortex (EMA/HMPC/246774/2009, final, 10 May 2011), 2011-05-10. ema.europa.eu
- Wang YH, et al. Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States. J Agric Food Chem 2013;61(18):4470-6 (PMID 23627682), 2013-05-08. pubmed.ncbi.nlm.nih.gov
- National Toxicology Program. TR-422: Toxicology and Carcinogenesis Studies of Coumarin in F344/N Rats and B6C3F1 Mice (Gavage Studies) (1993), 1993. ntp.niehs.nih.gov
- National Toxicology Program. TR-514: Toxicology and Carcinogenesis Studies of trans-Cinnamaldehyde (Microencapsulated) in F344/N Rats and B6C3F1 Mice (Feed Studies) (2004), 2004. ntp.niehs.nih.gov
- GBIF species API: IUCN Red List category for Cinnamomum verum J.Presl, 2026-10-29. api.gbif.org
Sources
- NCCIH. Cinnamon (Last Updated: November 2024), 2024-11. nccih.nih.gov
- Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev 2012, Issue 9 (CD007170), 2012-09-12. cochrane.org
- European Medicines Agency. Cinnamomi cortex (herbal medicine page), 2011-08-05. ema.europa.eu
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.